We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

ELITechGroup Acquires Freezing Point Osmometry Provider GONOTEC

By LabMedica International staff writers
Posted on 19 Jul 2021
ELITechGroup (Puteaux, France) has acquired GONOTEC (Berlin, Germany), thus uniting two osmometry market leaders.

The acquisition will also provides the industry with a full range of osmometry solutions that meet specific needs, enabling physicians to more rapidly and accurately diagnosis disease and determine the proper course of patient treatment. In addition, ELITechGroup will now have a direct market presence in Germany, enabling the company to serve customers with its entire portfolio of products and solutions directly.

Illustration
Illustration

"The strategic acquisition of GONOTEC expands the company's global capabilities to deliver innovative products to the in vitro diagnostics, biotech, chemical, environmental, food & beverage, pharmaceutical, and research market segments. With a combined 90+ years of innovation, we aim to become the number one osmometry company in the world," said Bryce McEuen, Vice President, Biomedical Systems. "In addition, the acquisition increases our capacity and geographic presence to serve laboratories with superior levels of service and customer support."

Related Links:
ELITechGroup
GONOTEC



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Gold Member
Hematology Analyzer
Medonic M32B

Latest Industry News

WHX Labs Dubai to Gather Global Experts in Antimicrobial Resistance at Inaugural AMR Leaders’ Summit
19 Jul 2021  |   Industry

BD and Penn Institute Collaborate to Advance Immunotherapy through Flow Cytometry
19 Jul 2021  |   Industry

Abbott Acquires Cancer-Screening Company Exact Sciences
19 Jul 2021  |   Industry